Telemedicine: Insulin pump controlled via the Global System for Mobile Communications (GSM)

Gröning, Riidiger; Remmerbach, Sven; Jansen, Alexander C.

doi:10.1016/j.ijpharm.2007.02.017

Cited by 6 publications

(6 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…As far as drug delivery is concerned, new tools are tilting health-care control from physicians to patients with the paradigm of the delivery of insulin using telemedicine (151). Three dimensional (3D) printing technologies emerge as an innovative approach to design pharmaceutical dosage forms for personalized medicine (152).…”

Section: Future Perspectives In Advancing Pbpk Models To Ensure Practmentioning

confidence: 99%

Enabling personalized cancer medicine decisions: The challenging pharmacological approach of PBPK models for nanomedicine and pharmacogenomics (Review)

et al. 2016

View full text Add to dashboard Cite

The existing tumor heterogeneity and the complexity of cancer cell biology critically demand powerful translational tools with which to support interdisciplinary efforts aiming to advance personalized cancer medicine decisions in drug development and clinical practice. The development of physiologically based pharmacokinetic (PBPK) models to predict the effects of drugs in the body facilitates the clinical translation of genomic knowledge and the implementation of in vivo pharmacology experience with pharmacogenomics. Such a direction unequivocally empowers our capacity to also make personalized drug dosage scheme decisions for drugs, including molecularly targeted agents and innovative nanoformulations, i.e. in establishing pharmacotyping in prescription. In this way, the applicability of PBPK models to guide individualized cancer therapeutic decisions of broad clinical utility in nanomedicine in real-time and in a cost-affordable manner will be discussed. The latter will be presented by emphasizing the need for combined efforts within the scientific borderlines of genomics with nanotechnology to ensure major benefits and productivity for nanomedicine and personalized medicine interventions.

show abstract

Section: Future Perspectives In Advancing Pbpk Models To Ensure Practmentioning

confidence: 99%

Enabling personalized cancer medicine decisions: The challenging pharmacological approach of PBPK models for nanomedicine and pharmacogenomics (Review)

et al. 2016

View full text Add to dashboard Cite

show abstract

“…A telemetric technique has been proposed to govern an insulin pump for drug release [18]. This technique is used to remotely control the time and rate of the drug.…”

Section: Implantable Drug Delivery Systemsmentioning

confidence: 99%

“…The drug sealed with a thin film is released at the desired time and rate by rupturing the thin film using electrochemical and electro-thermal means [16,18,[23][24][25][26]. Magnetic actuation has been proposed to minimize the overall size of the micropumps, which are activated by applying a magnetic field to a flexible magnetic reservoir containing a drug.…”

Section: Implantable Drug Delivery Systemsmentioning

confidence: 99%

Towards soft robotic devices for site-specific drug delivery

Alici

2015

Expert Review of Medical Devices

View full text Add to dashboard Cite

Considerable research efforts have recently been dedicated to the establishment of various drug delivery systems (DDS) that are mechanical/physical, chemical and biological/molecular DDS. In this paper, we report on the recent advances in site-specific drug delivery (site-specific, controlled, targeted or smart drug delivery are terms used interchangeably in the literature, to mean to transport a drug or a therapeutic agent to a desired location within the body and release it as desired with negligibly small toxicity and side effect compared to classical drug administration means such as peroral, parenteral, transmucosal, topical and inhalation) based on mechanical/physical systems consisting of implantable and robotic drug delivery systems. While we specifically focus on the robotic or autonomous DDS, which can be reprogrammable and provide multiple doses of a drug at a required time and rate, we briefly cover the implanted DDS, which are well-developed relative to the robotic DDS, to highlight the design and performance requirements, and investigate issues associated with the robotic DDS. Critical research issues associated with both DDSs are presented to describe the research challenges ahead of us in order to establish soft robotic devices for clinical and biomedical applications. Towards soft robotic devices for site-specific drug delivery Abstract Considerable research efforts have recently been dedicated to the establishment of various drug delivery systems (DDS) which are mechanical / physical, chemical and biological/molecular DDS. In this paper, we report on recent advances in site-specific drug delivery 1 based on mechanical / physical systems consisting of implantable and robotic drug delivery systems. While we specifically focus on the robotic or autonomous DDS, which can be reprogrammable and provide multiple doses of a drug at a required time and rate, we briefly cover the implanted DDS, which are well-developed relative to the robotic DDS, to highlight the design and performance requirements, and investigate issues associated with the robotic DDS. Critical research issues associated with both DDSs are presented to describe the research challenges ahead of us in order to establish really soft robotic devices for clinical and biomedical applications.

show abstract

“…The use of other technologies, such as telemedicine to control insulin pumps (Gröning et al, 2007) or remote controlled capsules (Pi et al, 2009) brings medication to an exciting phase. Fig.…”

Section: Enhanced Drug Deliverymentioning

confidence: 99%